Clinical trial
Gabapentin Kinetic Disposition and Renal Excretion: Role of Transporters for Organic Cations and the Effect of Glycemic Control in Patients With Neuropathic Pain.
NCT03047278 is registered in ClinicalTrials.gov with Natalia Valadares de Moraes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Gabapentin Kinetic Disposition and Renal Excretion: Role of Transporters for Organic Cations and the Effect of Glycemic Control in Patients With Neuropathic Pain.
- Lead sponsor
- Natalia Valadares de Moraes
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 1, 2015
- Completion date
- July 1, 2019
- Enrollment
- 29 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic neuropathy, painful, neuropathic pain, type 2 diabetes mellitus